Emmaus Life Sciences : Reports Q2 2023 Financial Results
Emmaus Life Sciences Reports Q2 2023 Financial Results Record Net Revenues Contributed to Income from Operations Sixth Straight Quarterly Increase in Net... -Today at 03:28 pm- MarketScreener
Stay updated with breaking news from Willis Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emmaus Life Sciences Reports Q2 2023 Financial Results Record Net Revenues Contributed to Income from Operations Sixth Straight Quarterly Increase in Net... -Today at 03:28 pm- MarketScreener
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,...
/PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, today announced that it has received marketing...
Sickle Cell Disease Treatment Commercially Available in Five GCC Countries TORRANCE, Calif., July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle cell disease treatment, today
Sickle Cell Disease Treatment Commercially Available in Five GCC Countries TORRANCE, Calif., July 13, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment,...